RJR-2429

From WikiMD's WELLNESSPEDIA

RJR-2429.svg

RJR-2429' is a chemical compound that acts as a nicotinic acetylcholine receptor (nAChR) agonist. It is primarily used in scientific research to study the effects of nAChR activation.

Chemical Structure and Properties[edit]

RJR-2429 is a synthetic compound with a complex chemical structure. It is classified as a nicotine analog due to its ability to bind to and activate nicotinic acetylcholine receptors. The molecular formula of RJR-2429 is C 10H 14N 2, and it has a molecular weight of 162.23 g/mol.

Mechanism of Action[edit]

RJR-2429 functions by binding to the nicotinic acetylcholine receptors, which are a type of ligand-gated ion channel found in the central nervous system and peripheral nervous system. Upon binding, it mimics the action of the neurotransmitter acetylcholine, leading to the opening of the ion channel and subsequent influx of sodium ions. This results in the depolarization of the neuron and the propagation of an action potential.

Research Applications[edit]

RJR-2429 is used extensively in neuroscience research to investigate the role of nicotinic acetylcholine receptors in various physiological and pathological processes. It has been studied in the context of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease, as well as in addiction research to understand the mechanisms underlying nicotine addiction.

Pharmacological Effects[edit]

The activation of nicotinic acetylcholine receptors by RJR-2429 can lead to a variety of pharmacological effects, including enhanced cognitive function, increased alertness, and improved memory. These effects are similar to those observed with nicotine, but RJR-2429 is often preferred in research due to its specificity and potency.

Safety and Toxicity[edit]

As with many research chemicals, the safety and toxicity profile of RJR-2429 is not fully understood. It is typically handled with caution in laboratory settings, and its use is restricted to controlled environments.

See Also[edit]

References[edit]


Stub icon

This medical article is a stub. You can help WikiMD by expanding the page.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=RJR-2429&oldid=5805471"